Merck KGaA announced that Dr. Stefan Oschmann will become a member of the Executive Board and General Partner of Merck KGaA. He succeeds Elmar Schnee, who leaves the company for personal reasons. In line with the duties of his predecessor, Stefan Oschmann will be responsible for both divisions Merck Serono and Consumer Health Care and personally assume the lead of the Merck Serono division as of January 1, 2011. Dr. Kai Beckmann will become a member of the Executive Board and General Partner of Merck KGaA effective April 1, 2011. He will be responsible for the newly created Executive Board position of Human Resources.
“Elmar Schnee has initiated and implemented many important strategic changes in our pharmaceuticals business. After restructuring our pharmaceuticals organization in France, he was appointed to the Executive Board in 2005 and had a crucial forming influence on our acquisition and integration of the biotech company Serono back in 2007. The market exceeding growth of Merck Serono since its creation is clear proof of his success. I sincerely thank Elmar Schnee for all these achievements and wish him all the best for the future,“ said Dr. Frank Stangenberg-Haverkamp, Chairman of the Board of Partners of E. Merck KG. The Board of Partners made these appointments.
Stangenberg-Haverkamp commented on the appointment of Stefan Oschmann: “Stefan Oschmann has worked for more than 20 years at the American company Merck & Co., recently as President of Emerging Markets, and has broad experience in managing international pharmaceutical markets. He is the ideal candidate to successfully drive the internationalization of Merck Serono and to advance our pharmaceutical research and development.“
“Kai Beckmann has proven his management skills especially in the IT business as well as Managing Director in Singapore and Malaysia,” said Stangenberg-Haverkamp. “Since 2007, he has pushed forward the modernization and globalization of our IT function in his role as Chief Technology Officer (CIO), which shows the change of our company within a function with global responsibility. We expect this experience will be valuable as member of the Executive Board responsible for Human Resources.”
Date: December 13, 2010
Source: Merck KGaA